Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force

  1. Averna, M.
  2. Banach, M.
  3. Bruckert, E.
  4. Drexel, H.
  5. Farnier, M.
  6. Gaita, D.
  7. Magni, P.
  8. März, W.
  9. Masana, L.
  10. Mello e Silva, A.
  11. Reiner, Z.
  12. Ros, E.
  13. Vrablik, M.
  14. Zambon, A.
  15. Zamorano, J.L.
  16. Stock, J.K.
  17. Tokgözoğlu, L.S.
  18. Catapano, A.L.
Revue:
Atherosclerosis

ISSN: 1879-1484,  0021-9150

Année de publication: 2021

Volumen: 325

Pages: 99-109

Type: Note

DOI: 10.1016/J.ATHEROSCLEROSIS.2021.03.039 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus